JP2020535811A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535811A5 JP2020535811A5 JP2020517953A JP2020517953A JP2020535811A5 JP 2020535811 A5 JP2020535811 A5 JP 2020535811A5 JP 2020517953 A JP2020517953 A JP 2020517953A JP 2020517953 A JP2020517953 A JP 2020517953A JP 2020535811 A5 JP2020535811 A5 JP 2020535811A5
- Authority
- JP
- Japan
- Prior art keywords
- binding molecule
- specific binding
- domain
- specific
- vnar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023149770A JP7818828B2 (ja) | 2017-09-27 | 2023-09-15 | 特異的結合分子 |
| JP2025127980A JP2025160405A (ja) | 2017-09-27 | 2025-07-31 | 特異的結合分子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762563948P | 2017-09-27 | 2017-09-27 | |
| US62/563,948 | 2017-09-27 | ||
| US201862667126P | 2018-05-04 | 2018-05-04 | |
| US62/667,126 | 2018-05-04 | ||
| PCT/EP2018/076333 WO2019063726A1 (en) | 2017-09-27 | 2018-09-27 | SPECIFIC BINDING MOLECULES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023149770A Division JP7818828B2 (ja) | 2017-09-27 | 2023-09-15 | 特異的結合分子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020535811A JP2020535811A (ja) | 2020-12-10 |
| JP2020535811A5 true JP2020535811A5 (enExample) | 2021-11-04 |
Family
ID=63720686
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020517953A Pending JP2020535811A (ja) | 2017-09-27 | 2018-09-27 | 特異的結合分子 |
| JP2023149770A Active JP7818828B2 (ja) | 2017-09-27 | 2023-09-15 | 特異的結合分子 |
| JP2025127980A Pending JP2025160405A (ja) | 2017-09-27 | 2025-07-31 | 特異的結合分子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023149770A Active JP7818828B2 (ja) | 2017-09-27 | 2023-09-15 | 特異的結合分子 |
| JP2025127980A Pending JP2025160405A (ja) | 2017-09-27 | 2025-07-31 | 特異的結合分子 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11919949B2 (enExample) |
| EP (2) | EP3688030B1 (enExample) |
| JP (3) | JP2020535811A (enExample) |
| KR (1) | KR102657978B1 (enExample) |
| CN (1) | CN111479825A (enExample) |
| CA (1) | CA3075367A1 (enExample) |
| WO (1) | WO2019063726A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109477084A (zh) * | 2016-07-19 | 2019-03-15 | 国立研究开发法人农业·食品产业技术综合研究机构 | 使用等离子体在植物细胞内导入物质的方法 |
| US11414785B2 (en) | 2019-08-13 | 2022-08-16 | Waters Technologies Corporation | Affinity resins and sample preparation devices based on cartilaginous fish IgNAR derived binding domains |
| GB202020152D0 (en) | 2020-12-18 | 2021-02-03 | Elasmogen Ltd | Fast-track humanisation of specific binding molecules |
| WO2023077287A1 (en) * | 2021-11-03 | 2023-05-11 | City university of hong kong shenzhen research institute | High-affinity anti-egfp and anti-sars-cov-2 vnar single domain antibodies and use thereof |
| GB202407865D0 (en) | 2024-06-03 | 2024-07-17 | Elasmogen Ltd | Self immolative compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| AU2002319544B2 (en) | 2001-08-10 | 2008-07-10 | Aberdeen University | Antigen binding domains from fish |
| DK1751181T3 (da) | 2004-06-02 | 2012-11-26 | Adalta Pty Ltd | BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNER |
| US8496933B2 (en) * | 2009-11-04 | 2013-07-30 | Laboratorios Silanes, S.A. De C.V. | VHNAR anti-cytokine domains |
| MY167125A (en) * | 2011-08-17 | 2018-08-13 | Glaxo Group Ltd | Modified proteins and peptides |
| WO2013167883A1 (en) | 2012-05-07 | 2013-11-14 | The University Court Of The University Of Aberdeen | Single domain binding molecule |
| JP6616284B2 (ja) * | 2013-04-23 | 2019-12-04 | ザ ユニバーシティ コート オブ ザ ユニバーシティ オブ アバディーン | 特異的結合分子の人工ライブラリー |
| EP3160995A2 (en) * | 2014-06-26 | 2017-05-03 | Ossianix Inc. | Semi-synthetic nurse shark vnar libraries for making and using selective binding compounds |
-
2018
- 2018-09-27 US US16/650,889 patent/US11919949B2/en active Active
- 2018-09-27 JP JP2020517953A patent/JP2020535811A/ja active Pending
- 2018-09-27 EP EP18780089.1A patent/EP3688030B1/en active Active
- 2018-09-27 CA CA3075367A patent/CA3075367A1/en active Pending
- 2018-09-27 CN CN201880062689.7A patent/CN111479825A/zh active Pending
- 2018-09-27 KR KR1020207009544A patent/KR102657978B1/ko active Active
- 2018-09-27 WO PCT/EP2018/076333 patent/WO2019063726A1/en not_active Ceased
- 2018-09-27 EP EP24218449.7A patent/EP4570826A3/en active Pending
-
2023
- 2023-09-15 JP JP2023149770A patent/JP7818828B2/ja active Active
-
2024
- 2024-02-13 US US18/440,437 patent/US12371484B2/en active Active
-
2025
- 2025-07-31 JP JP2025127980A patent/JP2025160405A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7046804B2 (ja) | 改良された血清アルブミン結合剤 | |
| JP2019522490A5 (enExample) | ||
| JP2019506841A5 (enExample) | ||
| JP2022502371A5 (enExample) | ||
| JP2017537627A5 (enExample) | ||
| JP2022512653A5 (enExample) | ||
| JP2012518425A5 (enExample) | ||
| JP2016053091A5 (enExample) | ||
| CN110835371A (zh) | 抗ccr8单克隆抗体及其应用 | |
| JP2021535756A (ja) | 単一ドメイン抗体に基づくｂｃｍａキメラ抗原受容体及びその使用 | |
| JP2011521662A5 (enExample) | ||
| JP2018502050A5 (enExample) | ||
| IL268620B2 (en) | Antibodies against LAG3 pharmaceutical formulations containing them, and their uses for cancer treatment | |
| JP2015500811A5 (enExample) | ||
| JP2021524275A5 (enExample) | ||
| JP2020536888A5 (enExample) | ||
| JP2010505830A5 (enExample) | ||
| JP2019527543A5 (enExample) | ||
| JP2017160222A5 (enExample) | ||
| JP2018527919A5 (enExample) | ||
| JP6907229B2 (ja) | ヒト化抗ｃｌｅｖｅｒ−１抗体およびその使用 | |
| JP2016524592A5 (enExample) | ||
| JP2021511041A5 (enExample) | ||
| JP2017529067A5 (enExample) | ||
| JP2015518479A5 (enExample) |